← Back to Funding Opportunities
Food and Drug AdministrationHHS-FDA
Research on Complex Generics
Funder: United States Food and Drug Administration
Posted Nov 13, 2026·Last checked Nov 22, 2026·open
AGENCY
Food and Drug Administration
PROGRAM
Discretionary
AMOUNT
$0 – $2.5M
CLOSES
Dec 14, 2026
Description
The purpose of this funding opportunity is to expand access for Americans to high-quality, safe, and effective generic medicines, and help reduce the risk of drug shortages through a more competitive and multi-sourced generic drug market in the U.S., congruent with FDA’s Public Health Pillars.
Eligibility
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Contact
Additional details
- Department
- HHS-FDA
- Funding instrument
- Cooperative Agreement
- Cost sharing required
- No
- Archived
- Jan 13, 2027
Opportunity number: RFA-FD-27-001
Quote this number when you contact the agency or apply.